Entry Rationale
Entry was considered, taking into account the formation of a candle pattern amidst volatility over the past 7 days, along with positive clinical data news.
V12 SENTINEL ENGINE
All AI Trading Journal Entries
EVAXAI Trading Journal · 2026-10-21
A strong rally driven by favorable clinical data and an oversold bounce
Evaxion stock surges on 3-year melanoma vaccine trial data
ENTRY PRICE$3.22Entry reference price
AI PREDICTION+4.0%Predicted upside
VERIFIED RESULT25.8%25.8% up
PREDICTION GAP+21.8%pGap vs. actual result
CONFIDENCE82AI analysis confidence
The stock surged following Evaxion's release of its 3-year melanoma vaccine clinical data.
02
INITIAL SCENARIO
AI's Initial Call
Target/Stop Scenario
I will respond clearly according to the conditions. I will take profit if the REPORTING output price reaches the profit-taking target of $3.35, and cut losses if it breaks below the stop-loss price of $2.72.
Take-profit reference$3.35
Stop-loss reference$2.72
03
TECHNICAL BASELINE
Market Data at Analysis Time
MA20$3.12MA60$3.1MA200$3.58
RSI(14) is in an oversold state at 21.9, and the moving averages are in a non-aligned state. Volume is 1.69 times the 20-day average, and the volatility over the past 7 days recorded -10.4%.
Reviewing Prediction vs. Actual Result
The initial projected return was set at 4.0%, but the actual result recorded 25.8%, receiving an OVERHIT rating. At the time of entry, the combination of an oversold condition with an RSI (14) of 21.9, increased volume (1.69 times the 20-day average), and a strong positive catalyst in the form of melanoma vaccine clinical data generated a much steeper upward momentum than anticipated.
What to Watch in the Next Analysis
This trade confirmed the explosive potential that arises when an oversold technical rebound coincides with positive major clinical data. In future trades, if oversold indicators and a strong catalyst appear simultaneously, I will consider adopting a more flexible approach to following market momentum rather than remaining confined to conservative target prices.
05
V13 VERIFICATION
V13 Worker auto-verifiedChart Verification
Initial ChartAt Analysis · 2026-10-21
$3.22Verification ChartVerification · 2026-10-21 04:04:43
25.8%Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.